• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SENSEONICS INC. EVERSENSE TRANSMITTER; EVERSENSE CONTINUOUS GLUCOSE MONITOR SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SENSEONICS INC. EVERSENSE TRANSMITTER; EVERSENSE CONTINUOUS GLUCOSE MONITOR SYSTEM Back to Search Results
Model Number 102208-904
Device Problem Imprecision (1307)
Patient Problem Hypoglycemia (1912)
Event Date 02/22/2023
Event Type  Injury  
Manufacturer Narrative
This report is being submitted retrospectively as part of internal review.The investigation analysis was performed on the user synced glucose data on data management system (dms), which is an eversense cloud platform.The investigation analysis could not confirm the reported event, as none of the provided sensor glucose (sg) and corresponding blood glucose (sg) values could be found on the dms for the date of the complaint ((b)(6) 2023).Alert history log shows that all the alerts for glucose values outside of the set threshold were appropriately asserted to the customer.The overall sensor performance , before and after the event, was evaluated and performance was found within expectations.No further investigation was found necessary for this incident.The customer's hcp treated the customer with bacsemi (nose spray) and gluca hypokit.The customer was advised to contact their hcp for any medical assistance.
 
Event Description
Senseonics was made aware of a serious adverse event where the patient / customer lost consciousness due to a hypoglycemia.The incident occurred on (b)(6) 2023 and her husband had to call the doctor who lives next door.It was reported that the sensor glucose (sg) reading was 198 mg/dl at 1:46 am and 181 mg/dl at 2:02 am.The blood glucose (bg) reading showed 28 mg/dl.The patient complained of not being alerted by the eversense system.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EVERSENSE TRANSMITTER
Type of Device
EVERSENSE CONTINUOUS GLUCOSE MONITOR SYSTEM
Manufacturer (Section D)
SENSEONICS INC.
20451 seneca meadows parkway
germantown MD 20876 7005
Manufacturer (Section G)
SENSEONICS INC.
20451 seneca meadows parkway
germantown MD 20876 7005
Manufacturer Contact
vallikannu somasundaram
20451 seneca meadows parkway
germantown, MD 20876-7005
MDR Report Key18116768
MDR Text Key327881137
Report Number3009862700-2023-00223
Device Sequence Number1
Product Code QHJ
Combination Product (y/n)Y
Reporter Country CodeGM
PMA/PMN Number
P160048
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Consumer
Reporter Occupation Other
Type of Report Initial
Report Date 11/10/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/10/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Device Expiration Date08/30/2023
Device Model Number102208-904
Device Catalogue NumberFG-3500-04-001
Device Lot Number132065
Was Device Available for Evaluation? No
Date Manufacturer Received04/14/2023
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured08/30/2022
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization;
-
-